Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients.

IF 1 4区 医学 Q4 ONCOLOGY Journal of Oncology Pharmacy Practice Pub Date : 2025-01-01 Epub Date: 2024-01-30 DOI:10.1177/10781552231225187
Pryscila Rodrigues Moreira, Leonardo Teodoro de Farias, Amanda Ribeiro Feitosa, Lunara Teles Silva, Tatyana Xavier Almeida Matteucci Ferreira, Mércia Pandolfo Provin, Rita Goreti Amaral, Ana Carolina Figueiredo Modesto
{"title":"Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients.","authors":"Pryscila Rodrigues Moreira, Leonardo Teodoro de Farias, Amanda Ribeiro Feitosa, Lunara Teles Silva, Tatyana Xavier Almeida Matteucci Ferreira, Mércia Pandolfo Provin, Rita Goreti Amaral, Ana Carolina Figueiredo Modesto","doi":"10.1177/10781552231225187","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology.</p><p><strong>Aim: </strong>To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil.</p><p><strong>Method: </strong>Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa<i>.</i></p><p><strong>Results: </strong>The presence of potential drug interaction, showed a lack of concordance between the databases (<i>k</i> = -0.115 [95% CI: 0.361-0.532], <i>p</i> = 0.003). Regarding the mechanism, a strong agreement was observed (<i>k</i> = 0.805, <i>p</i> < 0.001 [95% CI: 0.550-0.941]). The management concordance showed a fair agreement, 46.8% (<i>k</i> = 0.22, <i>p</i> < 0.001 [95% CI: 0.099-0.341]). Stratifying the categories, significant concordance was observed in \"Adjustment of dose + Monitoring\" (<i>k</i> = 0.302, <i>p</i> = 0.018) and \"Monitoring\" (<i>k</i> = 0.417, <i>p</i> = 0.001), while other categories did not reach statistical significance.</p><p><strong>Conclusion: </strong>Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.</p>","PeriodicalId":16637,"journal":{"name":"Journal of Oncology Pharmacy Practice","volume":" ","pages":"90-97"},"PeriodicalIF":1.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncology Pharmacy Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10781552231225187","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology.

Aim: To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil.

Method: Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa.

Results: The presence of potential drug interaction, showed a lack of concordance between the databases (k = -0.115 [95% CI: 0.361-0.532], p = 0.003). Regarding the mechanism, a strong agreement was observed (k = 0.805, p < 0.001 [95% CI: 0.550-0.941]). The management concordance showed a fair agreement, 46.8% (k = 0.22, p < 0.001 [95% CI: 0.099-0.341]). Stratifying the categories, significant concordance was observed in "Adjustment of dose + Monitoring" (k = 0.302, p = 0.018) and "Monitoring" (k = 0.417, p = 0.001), while other categories did not reach statistical significance.

Conclusion: Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对两个数据库进行一致性分析,以搜索肿瘤血液病患者潜在的药物相互作用。
导言:潜在的药物相互作用对患者安全有重大影响,尤其是在复杂的肿瘤血液学治疗中,有可能导致毒性或治疗失败。尽管目前已有用于潜在药物相互作用调查的数据库,但在一致率和分类方面仍存在差异。目的:分析巴西中西部地区一家大学医院用于研究血液病患者处方中潜在药物相互作用的两个数据库的一致性:方法:在巴西一家医院开展横断面研究。在 Micromedex® 和 UpToDate® 中对潜在的药物相互作用进行了搜索。变量包括:潜在药物相互作用的存在、严重程度、机制、管理和记录。数据按频率(绝对和相对)、科恩卡帕和弗莱斯卡帕进行分析:结果:在潜在药物相互作用方面,数据库之间缺乏一致性(k = -0.115 [95% CI: 0.361-0.532], p = 0.003)。在机制方面,观察到很强的一致性(k = 0.805,p k = 0.22,p k = 0.302,p = 0.018),"监测"(k = 0.417,p = 0.001),而其他类别没有达到统计学意义:我们的研究强调了潜在药物相互作用研究的差异性,揭示了不同数据库在严重程度分类、管理建议和记录方法上的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.70
自引率
7.70%
发文量
276
期刊介绍: Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines...
期刊最新文献
Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: Single-center retrospective study. Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan. Impact of adjunct bezlotoxumab for preventing Clostridioides difficile infection recurrence in patients post - hematopoietic stem cell transplantation. Prevalence and predictive factors of chemotherapy-induced peripheral neuropathy in cancer patients: A cross-sectional single-center study in Pakistan. Eyelash trichomegaly complicating pembrolizumab for colorectal cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1